These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24492651)

  • 1. Pharmacological evaluation of selective α2c-adrenergic agonists in experimental animal models of nasal congestion.
    Jia Y; Mingo GG; Hunter JC; Lieber GB; Palamanda JR; Mei H; Boyce CW; Koss MC; Yu Y; Cicmil M; Hey JA; McLeod RL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):75-84. PubMed ID: 24492651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha2-adrenoceptor agonists as nasal decongestants.
    Corboz MR; Mutter JC; Rivelli MA; Mingo GG; McLeod RL; Varty L; Jia Y; Cartwright M; Hey JA
    Pulm Pharmacol Ther; 2007; 20(2):149-56. PubMed ID: 16809058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat.
    Mcleod RL; Erickson CH; Mingo GG; Hey JA
    Am J Rhinol; 2001; 15(6):407-15. PubMed ID: 11777250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of decongestant activity of alpha 2-adrenoceptor agonists.
    Corboz MR; Rivelli MA; Mingo GG; McLeod RL; Varty L; Jia Y; Hey JA
    Pulm Pharmacol Ther; 2008; 21(3):449-54. PubMed ID: 17869148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrine.
    Erickson CH; McLeod RL; Mingo GG; Egan RW; Pedersen OF; Hey JA
    Am J Rhinol; 2001; 15(2):83-90. PubMed ID: 11345158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
    McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
    Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of allergic nasal congestion in dogs sensitized to ragweed.
    Rudolph K; Bice DE; Hey JA; McLeod RL
    Am J Rhinol; 2003; 17(4):227-32. PubMed ID: 12962193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of α2-adrenoceptors in electrical field stimulation-induced contraction of pig nasal mucosa and pharmacologic characterization of a novel α2C-adrenoceptor agonist.
    Corboz MR; Rivelli MA; Shah H; Boyce CW; McCormick KD; Chapman RW; Hunter JC
    Am J Rhinol Allergy; 2013; 27(2):84-90. PubMed ID: 23562194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory neuropeptides and nitric oxide in nasal vascular regulation.
    Rinder J
    Acta Physiol Scand Suppl; 1996; 632():1-45. PubMed ID: 8800374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat.
    Mingo GG; Corboz MR; Salisbury BG; McCormick KD; Boyce CW; Mukhopadhyay G; McLeod RL
    Pharmacology; 2010; 85(5):259-63. PubMed ID: 20375536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustic rhinometry in the dog: a novel large animal model for studies of nasal congestion.
    Koss MC; Yu Y; Hey JA; McLeod RL
    Am J Rhinol; 2002; 16(1):49-55. PubMed ID: 11895194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A).
    Corboz MR; Rivelli MA; McCormick KD; Wan Y; Shah H; Umland S; Lieber G; Jia Y; McLeod RL; Morgan C; Varty GB; Wu J; Feng KI; Boyce CW; Aslanian RG; Palamanda J; Nomeir AA; Korfmacher W; Hunter JC; Anthes JC; Hey JA
    J Pharmacol Exp Ther; 2011 Apr; 337(1):256-66. PubMed ID: 21233198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion.
    McLeod RL; Mingo GG; Herczku C; DeGennaro-Culver F; Kreutner W; Egan RW; Hey JA
    Am J Rhinol; 1999; 13(5):391-9. PubMed ID: 10582118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of a noninvasive, chronic, experimental dog model of nasal congestion.
    Koss MC; Yu Y; Hey JA; McLeod RL
    J Pharmacol Toxicol Methods; 2002; 47(1):11-7. PubMed ID: 12387934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nasal decongestion evaluated by acoustic rhinometry].
    Nagano E; Nonaka S
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Nov; 97(11):2075-84. PubMed ID: 7529833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
    Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
    Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantageous safety profile of a dual selective alpha(2C) agonist/alpha(2A) antagonist antinociceptive agent.
    Delaunois A; De Ron P; Dedoncker P; Rosseels ML; Cornet M; Jnoff E; Hanon E; Guyaux M; Depelchin BO
    Fundam Clin Pharmacol; 2014 Aug; 28(4):423-38. PubMed ID: 24020399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.
    Eskiizmir G; Hirçin Z; Ozyurt B; Unlü H
    Eur J Clin Pharmacol; 2011 Jan; 67(1):19-23. PubMed ID: 21069518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.